Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.

Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Längler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE.

Br J Haematol. 2015 Aug;170(4):539-49. doi: 10.1111/bjh.13462. Epub 2015 May 4.

PMID:
25940575
2.

First characterization of platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 3 (FHL-3).

Nakamura L, Bertling A, Brodde MF, Zur Stadt U, Schulz AS, Ammann S, Sandrock-Lang K, Beutel K, Zieger B, Kehrel BE.

Blood. 2015 Jan 8;125(2):412-4. doi: 10.1182/blood-2014-07-587568. No abstract available.

3.

[Therapy of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)].

Streif W, Knöfler R, Eberl W, Andres O, Bakchoul T, Bergmann F, Beutel K, Dittmer R, Gehrisch S, Gottstein S, Halimeh S, Haselböck J, Hassenpflug WA, Heine S, Holzhauer S, King S, Kirchmaier CM, Krause M, Kreuz W, Lösche W, Mahnel R, Maurer M, Nimtz-Talaska A, Olivieri M, Rott H, Schambeck ChM, Schedel A, Schilling FH, Schmugge M, Schneppenheim R, Scholz U, Scholz T, Schulze H, Siegemund A, Strauß G, Sykora KW, Wermes C, Wiegering V, Wieland I, Zieger B, Zotz RB; Paediatric Committee of the Society of Thrombosis and Haemostasis Research..

Hamostaseologie. 2014;34(4):269-75, quiz 276. doi: 10.5482/HAMO-2014040001. German.

PMID:
25370176
4.

Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area.

Bode SF, Bogdan C, Beutel K, Behnisch W, Greiner J, Henning S, Jorch N, Jankofsky M, Jakob M, Schmid I, Veelken N, Vraetz T, Janka G, Ehl S, Lehmberg K.

J Pediatr. 2014 Jul;165(1):147-153.e1. doi: 10.1016/j.jpeds.2014.03.047. Epub 2014 May 3.

PMID:
24797953
5.

Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis.

Lehmberg K, Albert MH, Beier R, Beutel K, Gruhn B, Kröger N, Meisel R, Schulz A, Stachel D, Woessmann W, Janka G, Müller I.

Haematologica. 2014 Jan;99(1):180-4. doi: 10.3324/haematol.2013.094730. Epub 2013 Oct 25.

6.

Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.

Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE; EBV-HLH Rituximab Study Group..

Br J Haematol. 2013 Aug;162(3):376-82. doi: 10.1111/bjh.12386. Epub 2013 May 21.

7.

Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.

Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G.

J Pediatr. 2013 Jun;162(6):1245-51. doi: 10.1016/j.jpeds.2012.11.081. Epub 2013 Jan 17.

PMID:
23333131
8.

Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.

Sperl D, Benesch M, Urban C, Lackner H, Sovinz P, Speicher MR, Uhrig S, Schwarzbraun T, Schwinger W, zur Stadt U, Beutel K, Janka G, Scarpatetti M, Seidel MG.

Klin Padiatr. 2012 Oct;224(6):386-9. doi: 10.1055/s-0032-1323836. Epub 2012 Nov 9.

PMID:
23143765
9.

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).

Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, Al-Jefri A, Beier R, Bomme Ousager L, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B, Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, zur Stadt U, Janka G.

Blood. 2012 Jun 21;119(25):6016-24. doi: 10.1182/blood-2011-12-398958. Epub 2012 Mar 26.

10.

A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.

Bryceson YT, Pende D, Maul-Pavicic A, Gilmour KC, Ufheil H, Vraetz T, Chiang SC, Marcenaro S, Meazza R, Bondzio I, Walshe D, Janka G, Lehmberg K, Beutel K, zur Stadt U, Binder N, Arico M, Moretta L, Henter JI, Ehl S.

Blood. 2012 Mar 22;119(12):2754-63. doi: 10.1182/blood-2011-08-374199. Epub 2012 Jan 31.

11.

Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.

Simon A, Müllenborn E, Prelog M, Schenk W, Holzapfel J, Ebinger F, Klabunde-Cherwon A, Faber J, Groll AH, Masjosthusmann K, Dohna-Schwake C, Beutel K, Dirkwinkel E, Lehrnbecher T, Ammann RA, Müller A.

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1435-42. doi: 10.1007/s10096-011-1461-1. Epub 2011 Nov 3.

PMID:
22048844
12.

Risk factors for early death in children with haemophagocytic lymphohistiocytosis.

Trottestam H, Berglöf E, Horne A, Onelöv E, Beutel K, Lehmberg K, Sieni E, Silfverberg T, Aricò M, Janka G, Henter JI.

Acta Paediatr. 2012 Mar;101(3):313-8. doi: 10.1111/j.1651-2227.2011.02501.x. Epub 2011 Nov 17.

PMID:
22017632
13.

Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis.

Lehrnbecher T, Salzmann-Manrique E, Soerensen J, Beutel K, Janka G, Gadner H, Minkov M.

Br J Haematol. 2012 Jan;156(1):138-41. doi: 10.1111/j.1365-2141.2011.08816.x. Epub 2011 Aug 16. No abstract available.

PMID:
21848890
14.

Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3.

Sieni E, Cetica V, Santoro A, Beutel K, Mastrodicasa E, Meeths M, Ciambotti B, Brugnolo F, zur Stadt U, Pende D, Moretta L, Griffiths GM, Henter JI, Janka G, Aricò M.

J Med Genet. 2011 May;48(5):343-52. doi: 10.1136/jmg.2010.085456. Epub 2011 Jan 19.

15.

Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5).

Sandrock K, Nakamura L, Vraetz T, Beutel K, Ehl S, Zieger B.

Blood. 2010 Dec 23;116(26):6148-50. doi: 10.1182/blood-2010-08-302943. No abstract available.

16.

Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency.

Rensing-Ehl A, Warnatz K, Fuchs S, Schlesier M, Salzer U, Draeger R, Bondzio I, Joos Y, Janda A, Gomes M, Abinun M, Hambleton S, Cant A, Shackley F, Flood T, Waruiru C, Beutel K, Siepermann K, Dueckers G, Niehues T, Wiesel T, Schuster V, Seidel MG, Minkov M, Sirkiä K, Kopp MV, Korhonen M, Schwarz K, Ehl S, Speckmann C.

Clin Immunol. 2010 Dec;137(3):357-65. doi: 10.1016/j.clim.2010.08.008. Epub 2010 Sep 15.

PMID:
20832369
17.

Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.

Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, Bondzio I, Gross-Wieltsch U, Schündeln M, Schütz B, Woessmann W, Groll AH, Strahm B, Pagel J, Speckmann C, Janka G, Griffiths G, Schwarz K, zur Stadt U, Ehl S.

Haematologica. 2010 Dec;95(12):2080-7. doi: 10.3324/haematol.2010.029389. Epub 2010 Sep 7.

18.

STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5.

Cetica V, Santoro A, Gilmour KC, Sieni E, Beutel K, Pende D, Marcenaro S, Koch F, Grieve S, Wheeler R, Zhao F, zur Stadt U, Griffiths GM, Aricò M.

J Med Genet. 2010 Sep;47(9):595-600. doi: 10.1136/jmg.2009.075341.

19.

Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations.

Meeths M, Bryceson YT, Rudd E, Zheng C, Wood SM, Ramme K, Beutel K, Hasle H, Heilmann C, Hultenby K, Ljunggren HG, Fadeel B, Nordenskjöld M, Henter JI.

Pediatr Blood Cancer. 2010 Apr;54(4):563-72. doi: 10.1002/pbc.22357.

PMID:
19953648
20.

Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.

zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, Strauss J, Kasper B, Nürnberg G, Becker C, Maul-Pavicic A, Beutel K, Janka G, Griffiths G, Ehl S, Hennies HC.

Am J Hum Genet. 2009 Oct;85(4):482-92. doi: 10.1016/j.ajhg.2009.09.005.

Supplemental Content

Loading ...
Support Center